EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

O‐GalNAc Glycosylation Activates MBL‐Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis

Xinyu Chen, Wei Bao, Kaiyuan Liu, Na Jing, Genyu Du, Luyao Jiang, Qian You, Yingchao Zhang, Penghui Xu, Chaping Cheng, Nan Wang, Xialian Xi und 13 weitere

Advanced Science · 2025

DOI: 10.1002/advs.202504809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Xinyu Chen und 24 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Systems Medicine for Cancer, Department of Urology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University…. Hauptthemen laut MEDLINE: Mannose-Binding Lectin, N-Acetylgalactosaminyltransferases, Liver Neoplasms, Blood Coagulation. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University, Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Liver metastasis is prevalent among patients with neuroendocrine prostate cancer (NEPC) and other types of neuroendocrine (NE) cancers, featuring with an aggressive clinical course and a dismal prognosis. However, the cellular and molecular mechanisms underlying liver‐specific metastatic tropism in NE cancers remain poorly understood. Intriguingly, it is found that NEPC liver metastatic foci are frequently associated with thrombi. NEPC cells express an aberrantly elevated level of glycosyltransferase Galnt9. Notably, the Galnt9‐mediated O‐GalNAc glycosylation on the cell membrane of NE cancer cells, particularly on the adhesion molecule Annexin A2, activates the mannose‐binding lectin (MBL) complement signaling in the liver. This cascade stimulates platelet activation and thrombus formation, ultimately facilitating hepatic metastasis of NEPC. Inhibition of O‐GalNAc glycosylation or knockdown of Galnt9 demonstrates efficacy in restraining the liver metastasis of NEPC, small cell lung cancer (SCLC), and colorectal neuroendocrine cancer. These findings identify Galnt9‐mediated O‐GalNAc glycosylation as a targetable mechanism driving liver metastasis through activation of MBL complement and coagulation cascades across a broad spectrum of NE cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mannose-Binding LectinN-AcetylgalactosaminyltransferasesLiver NeoplasmsBlood CoagulationNeuroendocrine TumorsGlycosylationHumansAnimalsMiceMaleCell Line, TumorPolypeptide N-acetylgalactosaminyltransferaseNeoplasm Metastasis

Stichwörter der Autor:innen

O‐GalNAc glycosylationcomplementglant9liver metastasismannose binding lectin (MBL)neuroendocrine prostate cancer

Substanzen

Mannose-Binding LectinN-AcetylgalactosaminyltransferasesPolypeptide N-acetylgalactosaminyltransferase

Autor:innen und Institutionen

  • State Key Laboratory of Systems Medicine for Cancer, Department of Urology, Ren Ji Hospital, Shanghai Cancer Institute, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Med-X research Institute, School of Biomedical Engineering, Shanghai Jiao Tong University, Shanghai, 200030, China.
  • Department of Pathology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.
  • Department of Surgery, Faculty of Medicine, The Chinese University of Hong Kong, Hong Kong, 999077, China.
  • S.H. Ho Urology Centre, Department of Surgery, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong, 999077, China.
  • Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200127, China.

ORCID-Profile: Kai Zhang, Helen He Zhu

Förderung

  • National Natural Science Foundation of China
  • Shanghai Pilot Program for Basic Research-Shanghai Jiao Tong University
  • Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant Support
  • Innovative Research Team of high level local universities in Shanghai; 111 Project
  • Collaborative Innovation Center for Clinical and Translational Science by Ministry of Edition & Shanghai
  • Renji Hospital grants:
  • State Key Laboratory of System Medicine for Cancer

Zitieren

APA

Chen, X., Bao, W., Liu, K., Jing, N., Du, G., Jiang, L., You, Q., Zhang, Y., Xu, P., Cheng, C., Wang, N., Xi, X., Wang, M., Liu, Y., Wang, J., Zhao, H., Zhang, S., Wu, D., Ng, C. F., …, & Zhu, H. H. (2025). O‐GalNAc Glycosylation Activates MBL‐Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis. Advanced Science. https://doi.org/10.1002/advs.202504809

Vancouver

Chen X, Bao W, Liu K, Jing N, Du G, Jiang L, et al. O‐GalNAc Glycosylation Activates MBL‐Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis. Advanced Science. 2025. doi:10.1002/advs.202504809

BibTeX
@article{Chen2025,
  author = {Chen, Xinyu and Bao, Wei and Liu, Kaiyuan and Jing, Na and Du, Genyu and Jiang, Luyao and You, Qian and Zhang, Yingchao and Xu, Penghui and Cheng, Chaping and Wang, Nan and Xi, Xialian and Wang, Mingyue and Liu, Yiyun and Wang, Jinming and Zhao, Huifang and Zhang, Shilei and Wu, Dinglan and Ng, Chi-Fai and Pan, Jiahua and Xue, Wei and Gao, Wei-Qiang and Zhang, Pengcheng and Zhang, Kai and Zhu, Helen He},
  title = {O‐GalNAc Glycosylation Activates MBL‐Mediated Complement and Coagulation Cascades to Drive Organotropic Metastasis},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202504809}
}
Kostenlos starten →